Cancer Treatment Today

The treatment described is in the province of alternative medicine and not allopathic medicine. The theory for the treatment that is described does not 'fit' allopathic physiology. Immuno-Technologies Cancer Clinic (ITL) is located 30 minutes (by plane) from Miami in Freeport, Bahamas. The Clinic and the alternative cancer treatment research center is directed by Dr. John Clement. Each alternative cancer treatment plan is customized to the person

Insulin potentiation therapy (IPT) refers to the use of insulin along with lower doses of chemotherapy to treat cancer. It is also sometimes used with other types of treatments for chronic diseases. IPT was developed in Mexico by Dr. Donato Perez Garcia, Sr., around the same time insulin had begun to be used in schizophrenics. In fact, some of those who support IPT note that, at this early stage, patients with cancer were also put into an insulin

The LESIH procedure relies on the use of a proprietary LASER System, of a wavelength not significantly absorbed by human tissue and emitting a low power broad beam. It is a form of fractionated Photo-dynamic Therapy. Both Photo-dynamic Therapy and Radio-fractionated Hyperthermia are FDA approved; however, due to limitations in the available delivery equipment, they cannot be utilized to treat larger tumors. The LAILT System I, proprietary of LASE

EDTA IV chelation is unproven for any indication. Ethylenediaminetetraacetic acid ("EDTA") is a synthetic amino acid first used in the 1940's for treatment of heavy metal poisoning. It is widely recognized as effective for that use as well as certain others, including emergency treatment of hypercalcemia and the control of ventricular arrhythmias associated with digitalis toxicity. Proponents claim that EDTA chelation therapy is effective against

Sodium phenylbutyrate is an orphan drug, marketed by Ucyclyd Pharma (Hunt Valley, USA) under the trade name Buphenyl and by Swedish Orphan International (Sweden) as Ammonaps. It, along with special diets, has been used to treat urea cycle disorders. It also has received an orphan drug designation by the FDA for treatment of acute promyelocytic leukemia. It appears to have a number of potentially useful effects. Sodium phenylbutyrate was given an

Imetelstat or GRN163L is a drug that blocks telomerase, and is already in clinical trials as a potential treatment for breast and lung cancer.Imetelstat is a short chain oligonucleotide that binds with high affinity and specificity to the catalytic site of telomerase, resulting in competitive inhibition of enzyme activity or cell death. Imetelstat demonstrated anti-tumor effects in a wide range of preclinical models of hematological and solid tumors.

The Oncosorb absorbtion column was invented by Dr. Lentz and described in a monograph, "Unleashing the Immune System: New Insights into Cancer", Equinox Press, 2010. The theory behind this treatment is that absorbing out TNF inhibitors will have an "immunostimulating" effect and be beneficial in cancer therapy. There are two isoforms; TNFR-1 (p55) and TNFR-2. TNFR-1 initiates the majority of the biological activities of TNF-α and is expressed on

Obstructive sleep apnea (OSA) is a prevalent disorder, which consists of recurring partial or complete occlusion of the upper airway during sleep, resulting in oxyhemoglobin desaturation and arousal. The associated excessive daytime sleepiness (EDS) and nocturnal symptoms such as snoring, witnessed apneas, and sleep disruption can lead to emotional, marital, social, occupational, and road safety impairment. Oral appliance therapy involves the selection,